A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing

Seminars in Oncology

Volumn 31, Issue SUPPL. 18, 2004, Pages 25-28

  Rosenthal, David I ^a   Chambers, Mark S ^a   Weber, Randal S ^a   Eisbruch, Avraham ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ADD ON THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CELL PROTECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EARLY CANCER; HEAD AND NECK CARCINOMA; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MUCOSA INFLAMMATION; OROPHARYNX CARCINOMA; PAROTID GLAND; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SALIVATION; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; TARGET CELL DESTRUCTION; XEROSTOMIA;

EID: 13844289421     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.12.008     Document Type: Conference Paper

References (16)

1. J.B. Epstein, S. Emerton, D.A. Kolbinson Quality of life and oral function following radiotherapy for head and neck cancer Head Neck 21 1999 1 11
2. I.H. Valdez, J.C. Atkinson, J.A. Ship Major salivary gland function in patients with radiation-induced xerostomia Flow rates and sialochemistry Int J Radiat Oncol Biol Phys 25 1993 41 47
3. L.B. Harrison, M.J. Zelefsky, D.G. Pfister Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue Head Neck 19 1997 169 175
4. N. Jha, H. Seikaly, J. Harris Prevention of radiation induced xerostomia by surgical transfer of submandibular gland into the submental space Radiother Oncol 66 2003 283 289
5. D.M. Brizel, T.H. Wasserman, M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
6. M.S. Chambers, B.B. Toth, J.W. Martin Oral and dental management of the cancer patient; patient Prevention and treatment of complications Support Care Cancer 3 1995 168 175
7. C. Dawes Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man J Dent Res 66 1987 648 653
8. A. Eisbruch, H.M. Kim, J.E. Terrell Xerostomia and its predictors following parotid sparing irradiation of head and neck Int J Radiat Oncol Biol Phys 50 2001 695 704
9. S.T. Sonis Oral complications J.F. Holland R.C. Bast Jr D.L. Moston Cancer Medicine (Ed 4) 1997 Lippincott, Williams and Wilkins Baltimore, MD 3255 3264
10. C.S. Scarantino, F. Leveque, C. Scott A Phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients Int J Radiat Oncol Biol Phys 51 2001 85 86
11. K.S. Chao, N. Majhail, C.J. Huang Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma Radiother Oncol 61 2001 275 280
12. L.A. Tabak In defense of the oral cavity Structure, biosynthesis, and function of salivary mucins Ann Rev Physiol 57 1995 547 564
13. A. Eisbruch, R.K. Ten Haken, H.M. Kim Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 577 587
14. C.M. Ammoson, B.S. Teh, T.J. Van Dosimetric predictors for xerostomia for head and neck cancer patients treated with SMART (simultaneous modulated accelerated radiation therapy) boost technique Int J Radiat Oncol Biol Phys 56 2003 136 144
15. M.I. Koukourakis, G. Kyrias, S. Kakolyris Subcutaneous administration of amifostine during fractionated radiotherapy A randomized phase II study J Clin Oncol 18 2000 2226 2233
16. D. Antonadou, M. Pepelassi, M. Synodinou Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer Int J Radiat Oncol Biol Phys 52 2002 739 747